JP2023071886A5 - - Google Patents

Download PDF

Info

Publication number
JP2023071886A5
JP2023071886A5 JP2023033133A JP2023033133A JP2023071886A5 JP 2023071886 A5 JP2023071886 A5 JP 2023071886A5 JP 2023033133 A JP2023033133 A JP 2023033133A JP 2023033133 A JP2023033133 A JP 2023033133A JP 2023071886 A5 JP2023071886 A5 JP 2023071886A5
Authority
JP
Japan
Prior art keywords
surfactant
pharmaceutical composition
pulmonary
particles
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023033133A
Other languages
English (en)
Japanese (ja)
Other versions
JP7629159B2 (ja
JP2023071886A (ja
Filing date
Publication date
Priority claimed from PCT/US2017/039094 external-priority patent/WO2017223502A1/en
Application filed filed Critical
Publication of JP2023071886A publication Critical patent/JP2023071886A/ja
Publication of JP2023071886A5 publication Critical patent/JP2023071886A5/ja
Application granted granted Critical
Publication of JP7629159B2 publication Critical patent/JP7629159B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023033133A 2016-06-24 2023-03-03 吸入用サーファクタント製剤 Active JP7629159B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201662354382P 2016-06-24 2016-06-24
US62/354,382 2016-06-24
US201662420932P 2016-11-11 2016-11-11
US62/420,932 2016-11-11
PCT/US2017/039094 WO2017223502A1 (en) 2016-06-24 2017-06-23 Surfactant formulations for inhalation
JP2018567655A JP7240178B2 (ja) 2016-06-24 2017-06-23 吸入用サーファクタント製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018567655A Division JP7240178B2 (ja) 2016-06-24 2017-06-23 吸入用サーファクタント製剤

Publications (3)

Publication Number Publication Date
JP2023071886A JP2023071886A (ja) 2023-05-23
JP2023071886A5 true JP2023071886A5 (cg-RX-API-DMAC10.html) 2024-02-27
JP7629159B2 JP7629159B2 (ja) 2025-02-13

Family

ID=59295343

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018567655A Active JP7240178B2 (ja) 2016-06-24 2017-06-23 吸入用サーファクタント製剤
JP2023033133A Active JP7629159B2 (ja) 2016-06-24 2023-03-03 吸入用サーファクタント製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018567655A Active JP7240178B2 (ja) 2016-06-24 2017-06-23 吸入用サーファクタント製剤

Country Status (10)

Country Link
US (2) US20190388444A1 (cg-RX-API-DMAC10.html)
EP (1) EP3474832B1 (cg-RX-API-DMAC10.html)
JP (2) JP7240178B2 (cg-RX-API-DMAC10.html)
AU (2) AU2017281931B2 (cg-RX-API-DMAC10.html)
CA (1) CA3028724A1 (cg-RX-API-DMAC10.html)
ES (1) ES3069827T3 (cg-RX-API-DMAC10.html)
MA (1) MA45451A (cg-RX-API-DMAC10.html)
MX (2) MX2018015969A (cg-RX-API-DMAC10.html)
WO (1) WO2017223502A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201900337B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017281931B2 (en) * 2016-06-24 2023-02-02 Merz Pharmaceuticals, Llc Surfactant formulations for inhalation
MX2020006634A (es) * 2017-12-21 2021-01-15 Civitas Therapeutics Inc Formulaciones de surfactantes para inhalacion.
CA3085943A1 (en) * 2017-12-21 2019-06-27 Civitas Therapeutics, Inc. Surfactant formulations for inhalation
WO2022082082A2 (en) * 2020-10-16 2022-04-21 Sherwood Russ Lehrman Lung treatment compositions
WO2023281523A1 (en) * 2021-07-09 2023-01-12 Indian Council Of Medical Research A pharmaceutical composition with a recombinant fragment of human surfactant protein-d for sars-cov-2 infection

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
CZ292186B6 (cs) * 1996-01-24 2003-08-13 Altana Pharma Ag Způsob výroby práškového prostředku s obsahem plicní povrchově aktivní látky, práškový prostředek a jeho použití
CA2382821A1 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US6586008B1 (en) * 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
JP2003522138A (ja) * 2000-02-11 2003-07-22 アルタナ ファルマ アクチエンゲゼルシャフト 慢性肺疾患の予防および治療のための肺表面活性剤の新規使用
WO2007084136A2 (en) * 2006-01-23 2007-07-26 Ony, Inc. Treatment of acute respiratory distress syndrome
CN101448405B (zh) * 2006-03-22 2013-03-06 Wm.雷格利Jr.公司 压缩的口香糖及其制备方法
WO2008011559A2 (en) 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
WO2008016497A2 (en) * 2006-07-31 2008-02-07 Corn Products International, Inc. Isomaltitol compositions and process for making isomaltitol compositions
US8496002B2 (en) 2007-06-12 2013-07-30 Civitas Therapeutics, Inc. Powder inhaler devices
WO2009026434A1 (en) * 2007-08-21 2009-02-26 Alkermes, Inc. Pulmonary pharmaceutical formulations
AU2017281931B2 (en) * 2016-06-24 2023-02-02 Merz Pharmaceuticals, Llc Surfactant formulations for inhalation

Similar Documents

Publication Publication Date Title
JP5575639B2 (ja) 改善された特性を有する再構成サーファクタント
EP2438086B1 (en) Improved reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c)
JP2010505937A (ja) 改善された性質を有する再構成サーファクタント
JP2010503731A (ja) 肺サーファクタント製剤および粘液クリアランスの促進方法
JPH10511090A (ja) 副甲状腺ホルモン,pth含有吸入用治療製剤
JP7629159B2 (ja) 吸入用サーファクタント製剤
WO2018108971A2 (en) Methods for treating inflammatory conditions of the lungs
US20070129297A1 (en) Treatment and prevention of asthma
JP2018514564A5 (cg-RX-API-DMAC10.html)
JP4883906B2 (ja) 再構成サーファクタントの調製用の改善された合成脂質混合物
US20240025970A1 (en) Lung treatment compositions
JP2003522138A (ja) 慢性肺疾患の予防および治療のための肺表面活性剤の新規使用
RU2748417C2 (ru) Стабильная фармацевтическая композиция, включающая восстановленную композицию легочного сурфактанта
JP2003501481A (ja) サーファクタントタンパク質b(sp−b)改変体およびサーファクタントタンパク質c(sp−c)改変体を含有する医薬品製剤
WO2014012559A1 (en) Granulocyte-macrophage colony-stimulating factor for the treatment of bronchial asthma
NZ765394B2 (en) Surfactant formulations for inhalation
NZ765394A (en) Surfactant formulations for inhalation
HK1185274B (en) Reconstituted surfactants having improved properties
WO2015110536A1 (en) Granulocyte-macrophage colony-stimulating factor for the treatment and prevention of severe forms of bronchial asthma
JP2003502441A (ja) サーファクタントタンパク質cエステル